Thursday, October 11, 2012
Epigenetic horrors await as Monsanto acquires key gene silencing technology for use in humans
Epigenetic horrors await as Monsanto acquires key gene silencing technology for use in humans: "The nascent field of epigenetics is making scientists and pharmaceutical houses drool all over the world. Recent discoveries that DNA is much more than a blueprint for protein building have opened the door to a brand new ATGC playground."
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment